RxDoctor Payments Data

Jeffrey Brumfield, MD

Clinical Cardiac Electrophysiology · Largo, FLNPI 1821124504

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (55.4%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 23.2%. Reporting peaked in 2023 at $6,626 and has fallen 58.6% since, to $2,745 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in FL, where the typical reported total is $25,729.

$26,071in general payments, 2019–2025

Across 380 payments — averaging $68.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$6K
  • Medtronic$6K
  • Abbott$5K
  • Atricure, Inc.$3K
  • Boston Scientific$2K
  • Biosense Webster, Inc.$1K
  • plus $3K from 32 others

What the payments were for

  • Consulting fees$1501%
  • Speaking & faculty fees$500%
  • Travel & lodging$14,43855%
  • Food & beverage$11,42744%
  • Education$60%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,071 in reported general payments places this provider in the 50th percentile of 249 clinical cardiac electrophysiology providers in Florida.

See all clinical cardiac electrophysiology providers in Florida →

Medicare billing

Part B allowed, 2024
$201,997
Medicare patients
355
Services billed
1,921

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban74$75,475
XareltoRivaroxaban15$21,479
Dofetilide36$6,259
Dabigatran EtexilateDabigatran Etexilate Mesylate17$5,928
Diltiazem 24hr Er (Cd)Diltiazem Hcl40$1,775
Metoprolol Succinate93$1,373
SotalolSotalol Hcl22$678
Amiodarone Hcl21$527
Rosuvastatin Calcium19$364
Losartan Potassium41$346
Metoprolol Tartrate35$243
Carvedilol28$224
Lisinopril20$132
Spironolactone11$106
Atorvastatin Calcium17$97

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$320$75,47574 claims
Johnson & JohnsonXarelto$520$21,47915 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 249 clinical cardiac electrophysiology providers in Florida.

Other clinical cardiac electrophysiology in Largo

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →